Promising OS with oncolytic virotherapy
- PMID: 35971000
- DOI: 10.1038/s41571-022-00678-2
Promising OS with oncolytic virotherapy
Comment on
-
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.Nat Med. 2022 Aug;28(8):1630-1639. doi: 10.1038/s41591-022-01897-x. Epub 2022 Jul 21. Nat Med. 2022. PMID: 35864254 Free PMC article. Clinical Trial.
References
Original article
-
- Todo, T. et al. Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial. Nat. Med. https://doi.org/10.1038/s41591-022-01897-x (2022) - DOI - PubMed - PMC
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
